Doravirine - CISMeF

Preferred Label : Doravirine;

NCIt definition : A pyridinone non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1), that is used to treat HIV infection. Upon oral administration, doravirine non-competitively inhibits HIV-1 reverse transcriptase (RT), thereby inhibiting HIV-1 viral replication.;

UNII : 913P6LK81M;

InChIKey : ZIAOVIPSKUPPQW-UHFFFAOYSA-N;

CAS number : 1338225-97-0;

Drug name : Pifeltro;

Details

Origin ID

C171848;

UMLS CUI

C4045491;

Currated CISMeF NLP mapping
- DORAVIRINE [MeSH Supplementary Concept]
- DORAVIRINE [MeSH concept]
- Doravirine [LOINC component]
- Doravirine [SMS substance]
- Doravirine (substance) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- DORAVIRINE [MeSH Supplementary Concept]
- Doravirine [LOINC component]
- Doravirine (substance) [SNOMED CT concept]
- Product containing doravirine (medicinal product) [SNOMED CT concept]
- doravirine [ATC Code]
Validated automatic mappings to BTNT
- doravirine [ATC Code]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients